8-81280617-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001444.3(FABP5):c.22G>A(p.Glu8Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000513 in 1,558,516 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001444.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FABP5 | NM_001444.3 | c.22G>A | p.Glu8Lys | missense_variant | 1/4 | ENST00000297258.11 | NP_001435.1 | |
LNMICC | NR_186603.1 | n.93-241C>T | intron_variant | |||||
LNMICC | NR_186604.1 | n.106-241C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FABP5 | ENST00000297258.11 | c.22G>A | p.Glu8Lys | missense_variant | 1/4 | 1 | NM_001444.3 | ENSP00000297258.6 | ||
LNMICC | ENST00000517670.1 | n.59C>T | non_coding_transcript_exon_variant | 1/2 | 2 | |||||
LNMICC | ENST00000518880.1 | n.115-241C>T | intron_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152136Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000120 AC: 2AN: 167328Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 88460
GnomAD4 exome AF: 0.00000498 AC: 7AN: 1406380Hom.: 0 Cov.: 31 AF XY: 0.00000432 AC XY: 3AN XY: 694312
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152136Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74322
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 10, 2024 | The c.22G>A (p.E8K) alteration is located in exon 1 (coding exon 1) of the FABP5 gene. This alteration results from a G to A substitution at nucleotide position 22, causing the glutamic acid (E) at amino acid position 8 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at